Alyeska Investment Group L.P. lifted its position in Endava plc (NYSE:DAVA - Free Report) by 80.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,806,044 shares of the company's stock after buying an additional 805,903 shares during the quarter. Alyeska Investment Group L.P. owned about 3.06% of Endava worth $55,807,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also modified their holdings of the company. Oppenheimer Asset Management Inc. acquired a new stake in shares of Endava during the 4th quarter worth approximately $215,000. Natixis Advisors LLC boosted its stake in Endava by 44.8% during the fourth quarter. Natixis Advisors LLC now owns 45,340 shares of the company's stock worth $1,401,000 after buying an additional 14,023 shares in the last quarter. Robeco Institutional Asset Management B.V. boosted its stake in Endava by 13.9% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 204,300 shares of the company's stock worth $6,313,000 after buying an additional 25,000 shares in the last quarter. Charles Schwab Investment Management Inc. increased its holdings in Endava by 35.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 27,289 shares of the company's stock valued at $843,000 after buying an additional 7,124 shares during the period. Finally, Sei Investments Co. raised its stake in shares of Endava by 26.1% in the 4th quarter. Sei Investments Co. now owns 118,095 shares of the company's stock valued at $3,649,000 after buying an additional 24,426 shares in the last quarter. 62.23% of the stock is owned by institutional investors.
Endava Stock Performance
Shares of DAVA stock traded up $0.25 during trading hours on Wednesday, hitting $19.02. 428,006 shares of the company were exchanged, compared to its average volume of 485,353. Endava plc has a 52-week low of $16.60 and a 52-week high of $34.94. The company has a current ratio of 1.90, a quick ratio of 1.90 and a debt-to-equity ratio of 0.21. The firm has a fifty day simple moving average of $19.72 and a 200 day simple moving average of $26.10. The stock has a market capitalization of $1.12 billion, a price-to-earnings ratio of 172.91, a P/E/G ratio of 2.26 and a beta of 1.25.
Endava (NYSE:DAVA - Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.18). Endava had a return on equity of 0.89% and a net margin of 0.74%. The company had revenue of $250.63 million for the quarter, compared to analysts' expectations of $197.33 million. Research analysts predict that Endava plc will post 0.57 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several equities analysts recently issued reports on DAVA shares. Susquehanna cut their price target on shares of Endava from $55.00 to $50.00 and set a "positive" rating for the company in a report on Friday, February 21st. Needham & Company LLC reduced their price objective on Endava from $43.00 to $38.00 and set a "buy" rating on the stock in a report on Friday, February 21st. Finally, Morgan Stanley increased their price objective on Endava from $33.00 to $35.00 and gave the company an "equal weight" rating in a research report on Friday, January 31st. Four equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $38.51.
View Our Latest Analysis on DAVA
Endava Company Profile
(
Free Report)
Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
Further Reading
Before you consider Endava, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Endava wasn't on the list.
While Endava currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
